Latest Period
Q1 2026
Security Snapshot
Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT) Institutional Ownership
CUSIP: 786700104
13F Institutional Holders and Ownership History from Q3 2023 to Q1 2026
Institutions Reporting
88
Shares (Excl. Options)
13,353,997
Price
$5.22
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Series A Common Stock, $0.0001 par value per share
- Symbol
- SGMT on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 13,353,997
- Total 13F value
- $69,764,298
- Portfolio coverage rank
- 0%
- Share change
- -991,474
- Value change
- -$5,892,432
- Number of holders
- 88
- Shares outstanding
- 31,278,271
- SEC-reported price per share
- $7.65
- Insider filing price
- $7.65
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SGMT - Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share is tracked under CUSIP 786700104.
- 88 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 86 to 88 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $85,220,750 to $69,764,298.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 88 institutions filings for Q1 2026.
Security key
786700104
Latest holder period
Q1 2026
13F holders
88
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
SGMT full holder history
Sagimet Biosciences Inc. SEC filings
Sagimet Biosciences Inc. company facts
Sagimet Biosciences Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 786700104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
SGMT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| AP11 Ltd | 4.9% | -10% | $5,055,597 | -$504,198 | 1,504,642 | -9.1% | AP11 Limited | 24 Jun 2025 |
| Woodline Partners LP | 4.8% | -44% | $10,299,309 | -$7,211,088 | 1,501,357 | -41% | Woodline Partners LP | 30 Sep 2025 |
| Blue Owl Capital Holdings LP | 4.3% | $4,527,659 | 1,323,877 | Blue Owl Capital Holdings LP | 31 Dec 2024 |
As of 31 Mar 2026, 88 institutional investors reported holding 13,353,997 shares of Sagimet Biosciences Inc. - Series A Common Stock, $0.0001 par value per share (SGMT). This represents 43% of the company’s total 31,278,271 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
38%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 3.5% | 1,098,919 | 0% | 0% | $5,741,852 |
| Woodline Partners LP | 3.2% | 1,000,943 | 0% | 0.02% | $5,229,927 |
| MARSHALL WACE, LLP | 3.1% | 966,253 | +24% | 0.01% | $5,043,840 |
| BAKER BROS. ADVISORS LP | 3% | 952,996 | 0% | 0.03% | $4,979,404 |
| Affinity Asset Advisors, LLC | 2.8% | 868,020 | -24% | 0.27% | $4,535,405 |
| MILLENNIUM MANAGEMENT LLC | 2.8% | 862,303 | +47% | 0% | $4,505,533 |
| BlackRock, Inc. | 2.6% | 799,943 | -1.7% | 0% | $4,179,702 |
| HHLR ADVISORS, LTD. | 2.3% | 724,800 | 0% | 0.23% | $3,787,080 |
| RENAISSANCE TECHNOLOGIES LLC | 2% | 625,469 | +83% | 0.01% | $3,268,076 |
| D. E. Shaw & Co., Inc. | 1.3% | 411,570 | -15% | 0% | $2,150,453 |
| Blue Owl Capital Holdings LP | 1.1% | 333,877 | -73% | 0.47% | $1,744,507 |
| RAYMOND JAMES FINANCIAL INC | 1% | 317,550 | +11% | 0% | $1,659,199 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.99% | 309,522 | +4.6% | 0% | $1,618,055 |
| Hudson Bay Capital Management LP | 0.97% | 303,223 | -0.41% | 0.01% | $1,584,340 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.96% | 299,641 | 0% | 0.03% | $1,565,624 |
| UBS Group AG | 0.94% | 293,934 | +46% | 0% | $1,535,806 |
| DIMENSIONAL FUND ADVISORS LP | 0.87% | 271,217 | +99% | 0% | $1,414,594 |
| Pale Fire Capital SE | 0.71% | 221,875 | 0% | 0.1% | $1,159,297 |
| Point72 Asset Management, L.P. | 0.6% | 187,564 | +6.7% | 0% | $980,022 |
| Qube Research & Technologies Ltd | 0.58% | 182,738 | +64% | 0% | $954,806 |
| GOLDMAN SACHS GROUP INC | 0.54% | 169,259 | +34% | 0% | $884,379 |
| VANGUARD FIDUCIARY TRUST CO | 0.52% | 162,618 | 0% | 0% | $849,679 |
| FNY Investment Advisers, LLC | 0.48% | 149,761 | +4.8% | 0.35% | $782,000 |
| STATE STREET CORP | 0.41% | 128,788 | +9.7% | 0% | $672,917 |
| 683 Capital Management, LLC | 0.4% | 126,349 | 0% | 0.06% | $660,174 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
11
Latest
Q1 2026
Rows shown
1-11 of 11
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 13,353,997 | $69,764,298 | -$5,892,432 | $5.22 | 88 |
| 2025 Q4 | 14,395,244 | $85,220,750 | +$8,789,236 | $5.92 | 86 |
| 2025 Q3 | 12,635,689 | $86,680,189 | +$6,909,222 | $6.86 | 72 |
| 2025 Q2 | 11,676,267 | $88,988,335 | +$3,493,936 | $7.62 | 67 |
| 2025 Q1 | 13,776,513 | $44,920,783 | -$15,209,275 | $3.26 | 69 |
| 2024 Q4 | 17,500,774 | $78,763,978 | -$8,862,770 | $4.50 | 66 |
| 2024 Q3 | 19,656,790 | $54,446,688 | -$7,224,186 | $2.77 | 63 |
| 2024 Q2 | 20,925,200 | $71,568,836 | -$7,461,714 | $3.42 | 81 |
| 2024 Q1 | 22,609,183 | $122,544,913 | +$44,339,223 | $5.42 | 81 |
| 2023 Q4 | 14,445,035 | $76,118,157 | -$8,948,267 | $5.42 | 51 |
| 2023 Q3 | 11,717,467 | $103,113,019 | +$103,113,019 | $8.80 | 47 |